These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 23412770)

  • 1. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.
    Karihtala P; Auvinen P; Kauppila S; Haapasaari KM; Jukkola-Vuorinen A; Soini Y
    Breast Cancer Res Treat; 2013 Feb; 138(1):81-90. PubMed ID: 23412770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
    Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ
    Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vimentin as a poor prognostic factor for triple-negative breast cancer.
    Yamashita N; Tokunaga E; Kitao H; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Aishima S; Morita M; Maehara Y
    J Cancer Res Clin Oncol; 2013 May; 139(5):739-46. PubMed ID: 23354842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic Mineralocorticoid Receptor Expression Predicts Dismal Local Relapse-free Survival in Non-triple-negative Breast Cancer.
    Jääskeläinen A; Jukkola A; Haapasaari KM; Auvinen P; Soini Y; Karihtala P
    Anticancer Res; 2019 Nov; 39(11):5879-5890. PubMed ID: 31704812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIP1 predicts progression and poor prognosis in pharyngeal squamous cell carcinoma.
    Jouppila-Mättö A; Mannermaa A; Sironen R; Kosma VM; Soini Y; Pukkila M
    Histol Histopathol; 2015 May; 30(5):569-79. PubMed ID: 25412653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.
    Liu H; Fan Q; Zhang Z; Li X; Yu H; Meng F
    Hum Pathol; 2008 Feb; 39(2):167-74. PubMed ID: 18045647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytologic features of triple-negative breast carcinoma.
    Bonzanini M; Morelli L; Bonandini EM; Leonardi E; Pertile R; Dalla Palma P
    Cancer Cytopathol; 2012 Dec; 120(6):401-9. PubMed ID: 22833438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centrally necrotizing carcinoma of the breast: clinicopathological analysis of 33 cases indicating its basal-like phenotype and poor prognosis.
    Yu L; Yang W; Cai X; Shi D; Fan Y; Lu H
    Histopathology; 2010 Aug; 57(2):193-201. PubMed ID: 20716161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
    Gregory PA; Bert AG; Paterson EL; Barry SC; Tsykin A; Farshid G; Vadas MA; Khew-Goodall Y; Goodall GJ
    Nat Cell Biol; 2008 May; 10(5):593-601. PubMed ID: 18376396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological characteristics of triple negative breast cancer at a tertiary care hospital in India.
    Dogra A; Doval DC; Sardana M; Chedi SK; Mehta A
    Asian Pac J Cancer Prev; 2014; 15(24):10577-83. PubMed ID: 25605142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Among triple-negative breast cancers, HER2(0) breast cancer shows a strong tendency to be basal-like compared with HER2(1+) breast cancer: preliminary results.
    Nakagawa M; Bando Y; Nagao T; Takai C; Ohnishi T; Honda J; Moriya T; Izumi K; Takahashi M; Tangoku A; Sasa M
    Breast Cancer; 2012 Jan; 19(1):54-9. PubMed ID: 21465226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.
    Rodríguez-Pinilla SM; Sarrió D; Honrado E; Moreno-Bueno G; Hardisson D; Calero F; Benítez J; Palacios J
    J Clin Pathol; 2007 Sep; 60(9):1006-12. PubMed ID: 17105822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factors zeb1, twist and snai1 in breast carcinoma.
    Soini Y; Tuhkanen H; Sironen R; Virtanen I; Kataja V; Auvinen P; Mannermaa A; Kosma VM
    BMC Cancer; 2011 Feb; 11():73. PubMed ID: 21324165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and transcriptional regulators of spontaneous epithelial-mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma.
    Lien HC; Yu HC; Yu WH; Lin SF; Chen TW; Chen IC; Hsiao LP; Yeh LC; Li YC; Lo C; Lu YS
    Breast Cancer Res; 2024 Sep; 26(1):130. PubMed ID: 39256881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of epithelial-mesenchymal transition process during breast cancer progression - the impact of molecular subtype and stromal composition.
    Markiewicz A; Topa J; Popęda M; Szade J; Skokowski J; Wełnicka-Jaśkiewicz M; Żaczek A
    Acta Biochim Pol; 2021 Aug; 68(3):385-392. PubMed ID: 34432400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
    Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
    Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas.
    Karihtala P; Kauppila S; Soini Y; Arja-Jukkola-Vuorinen
    BMC Cancer; 2011 Jun; 11():262. PubMed ID: 21693047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.